FDA Staff Flags Concerns on Merck ' s Chronic Cough Drug FDA Staff Flags Concerns on Merck ' s Chronic Cough Drug

The U.S. health regulator ' s staff on Wednesday flagged concerns that data on Merck ' s chronic cough drug might not be enough to prove the treatment ' s meaningful benefit.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news
More News: Cough | Health | Merck | Primary Care